CHMP gave a positive opinion for treating BMS' cell-therapy Breyanzi for relapsed or refractory follicular lymphoma Bristol Myers Squibb...

The European Commission has granted approval for the use of Rybrevant ( amivantamab) in combination with Lazcluze ( lazertinib) as a...

The European Commission (EC) has approved Kisqali (ribociclib) in combination with aromatase inhibitors (AI) for the treatment of...

Alhemo recommended for European approval as first daily subcutaneous prophylactic treatment for haemophilia A or B patients with...

Merck's Keytruda (pembrolizumab), combined with Padcev (enfortumab vedotin), has received approval from the European Commission (EC) as a...

In a significant development, the European Commission has expanded the approval of Arexvy, GSK's respiratory syncytial virus (RSV)...

EU Approval for Roche’s PiaSky as First Monthly Subcutaneous Treatment for PNH Roche has announced that the European Commission has...

Regeneron Pharmaceuticals has announced that the European Commission (EC) has granted approval for Ordspono (odronextamab) for the...

Great Britain has granted approval for Leqembi (lecanemab), a treatment designed for adults with mild cognitive impairment (MCI) and...

Tepkinly (epcoritamab) has received conditional marketing authorization from the European Commission (EC) as a monotherapy for treating...

Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has granted approval for Dupixent (dupilumab) as an...

Lynparza and Imfinzi Combination Recommended for EU Approval by CHMP for Advanced or Recurrent Endometrial Cancer AstraZeneca announced...

Roche announced that the European Commission has approved Alecensa (alectinib) as the first targeted adjuvant treatment for adults with...

Biogen has announced that the European Commission (EC) has granted marketing authorization for QALSODY (tofersen), marking the first...

January 08, 2024 EC approved Rystiggo for gMG UCB has received approval from the European Commission (EC) for Rystiggo (rozanolixizumab)...

Novartis' Fabhalta Receives Favorable CHMP Opinion for PNH Treatment Advancement UCB's Bimzelx (bimekizumab) garners favorable CHMP...

Voydeya Received CHMP Position Opinion for Residual Haemolytic Anaemia for PNH The CHMP of the European Medicines Agency (EMA) has...

November 16, 2023 UK Grants First-Ever Approval for CRISPR/Cas9 Gene-Edited Therapy, CASGEVY, in Sickle Cell Disease and Thalassemia...

NEW DRUG APPROVALS Santhera Pharmaceuticals' Agamree received CHMP's positive opinion for DMD. Santhera Pharmaceuticals has received a...

European Commission (EC) has granted conditional marketing authorization for AbbVie's Tepkinly (epcoritamab) as a standalone treatment...

JULY 2023 CHMP POSITIVE OPINIONS The EMA's CHMP gave a positive opinion for ViiV Healthcare's cabotegravir, marking a significant...

Eisai and Biogen have jointly announced the submission of a Marketing Authorization Application (MAA) for lecanemab, an investigational...

DECEMBER 2022 CHMP POSITIVE OPINIONS CSL's gene therapy, Hemgenix, received a positive CHMP opinion for treating Hemophilia B. The CHMP...

December 21, 2022 EMA approved Lynparza, Zytiga, and prednisone or prednisolone combination for metastatic castration-resistant prostate...

December 08, 2022 Sanofi/GSK's and Novavax's COVID-19 vaccine received a favorable opinion from HAS as a booster dose vaccine. HAS...

Oct 6, 2022 Merck and Ridgeback announced that molnupiravir has no efficacy in vaccinated adults. Merck and Ridgeback announced two...

Bristol Myers Squibb announced that the European Commission had approved Opdualag (nivolumab and relatlimab) for treating advanced...

European Commission has approved Scemblix (asciminib) for treating adult patients with Philadelphia chromosome-positive chronic myeloid...

Roche has announced that the European Commission approved Polivy (polatuzumab vedotin) in combination with rituximab plus...

December 2021 IQWIG says Rinvoq has added benefit at higher doses, but with safety issues IQWIG has assessed the benefit assessment of...

Ronapreve (casirivimab / imdevimab) approved for treating and preventing COVID19 in adults and adolescents Celltrion's Regkirona...

GlaxoSmithKline announced that it received approval for expanded use of Benlysta (belimumab) for lupus nephritis in Europe. The drug is...

HAS recommended the user of mRNA vaccines for a population already administered with AstraZeneca vaccine AstraZeneca’s COVID19 vaccine...

GSK has announced that the US FDA has approved Jemperli (dostarlimab), a programmed death receptor-1 (PD-1) for endometrial cancer. The...

NHS England recommended the use of Roche's Phesgo (pertuzumab/trastuzumab) for treating HER2-positive breast cancer. HER2-positive breast...

March 2021 CHMP Positive Opinion Verastem’s Copiktra (duvelisib) received CHMP positive opinion for treating CLL and FL CHMP gave a...

Novartis entered a strategic collaboration with BeiGene to license tislelizumab; to market in major markets outside China, including...

Biogen has announced that the first patient with spinal muscular atrophy (SMA) has been treated with Spinraza (nusinersen), who were...

Kite announced that it received conditional approval in Europe for Tecartus (brexucabtagene autoleucel). Tecartus is a chimeric antigen...

Johnson and Johnson announced that the European Commission had approved an Advance Purchase Agreement, according to which the European...

HAS announced that Gilead has withdrawn the refund request of Veklury (remdesivir) for COVID19 patients. Also read: HEALTHCARE SYSTEM IN...

BMS Opdivo for Resected Esophageal or Gastroesophageal Junction Cancer Bristol Myers Squibb has presented the results of Phase 3...

AstraZeneca has announced that the randomized clinical trials of AZD1222, a vaccine developed Oxford, has been paused because of the...

GSK has announced that the European Commission has granted approval for Blenrep (belantamab mafodotin) for treating adult patients with...

ADAKVEO (crizanlizumab) Adakveo received a positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) for...

AstraZeneca and Merck have announced that they have received the approval of Lynparza (Olaparib) for germline BRCA-mutated metastatic...

Gilead Sciences has announced that the European Commission has granted conditional marketing authorization for Veklury (remdesivir) for...

Johnson and Johnson announced that the European Commission had approved the Ebola vaccine to prevent the Ebola virus disease. Janssen has...

GSK has announced that Clover Biopharmaceuticals initiated the Phase 1 trial of COVID-19 vaccine SCB-2019. The vaccine was given in...